Korro Bio, Inc.
KRRO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $117 | $163 | $340 |
| - Cash | $25 | $34 | $64 | $56 |
| + Debt | $42 | $45 | $45 | $45 |
| Enterprise Value | – | $128 | $144 | $329 |
| Revenue | $1 | $1 | $3 | $2 |
| % Growth | -25.3% | -42.7% | 12.3% | – |
| Gross Profit | $1 | $1 | $3 | $2 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$17 | -$26 | -$24 | -$22 |
| % Margin | -1,548.8% | -1,779.1% | -933.1% | -959.4% |
| Net Income | -$18 | -$26 | -$23 | -$21 |
| % Margin | -1,657% | -1,765.1% | -917.1% | -933.5% |
| EPS Diluted | -1.92 | -2.74 | -2.49 | -2.26 |
| % Growth | 29.9% | -10% | -10.2% | – |
| Operating Cash Flow | -$17 | -$19 | -$24 | -$7 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$17 | -$19 | -$25 | -$9 |